Tenascin-X: A candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome?

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 504-505

  Zweers, M C ^a   Kucharekova, M ^b   Schalkwijk, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TENASCIN; TENASCIN X; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC TEST; EHLERS DANLOS SYNDROME; GENETIC DISORDER; HUMAN; JOINT HYPERMOBILITY; PRIORITY JOURNAL; SCORING SYSTEM;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; EHLERS-DANLOS SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JOINT INSTABILITY; MALE; TENASCIN;

EID: 14144250372     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.026559     Document Type: Article

References (6)

1. Russek LN. Hypermobility syndrome. Phys Ther 1999;79:591-9.
2. Grahame R. Joint hypermobility and genetic collagen disorders: are they related? Arch Dis Child 1999;80:188-91.
3. Grahame R, Bird HA, Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 2000;27:1777-9.
4. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31-7.
5. Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M, et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 2003;73:214-17.
6. Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, Van Vlijmen IM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001;345:1167-75.